CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 36.679
EU - Europa 9.191
AS - Asia 3.677
SA - Sud America 38
AF - Africa 31
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 16
Totale 49.656
Nazione #
US - Stati Uniti d'America 36.146
IE - Irlanda 1.977
CN - Cina 1.853
IT - Italia 1.585
UA - Ucraina 1.518
SE - Svezia 1.482
HK - Hong Kong 1.213
DE - Germania 796
GB - Regno Unito 678
CA - Canada 512
FI - Finlandia 364
VN - Vietnam 272
RU - Federazione Russa 257
FR - Francia 199
TR - Turchia 130
NL - Olanda 76
DK - Danimarca 73
IN - India 72
AT - Austria 42
SG - Singapore 37
BE - Belgio 34
JP - Giappone 28
BR - Brasile 21
MX - Messico 18
IR - Iran 17
AU - Australia 15
ES - Italia 13
PL - Polonia 12
RO - Romania 12
BG - Bulgaria 11
EU - Europa 11
CZ - Repubblica Ceca 10
NZ - Nuova Zelanda 9
AR - Argentina 8
CL - Cile 8
GR - Grecia 8
ID - Indonesia 8
MY - Malesia 8
NG - Nigeria 8
TH - Thailandia 8
HU - Ungheria 7
KR - Corea 7
PT - Portogallo 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
ZA - Sudafrica 6
A2 - ???statistics.table.value.countryCode.A2??? 5
NO - Norvegia 5
CH - Svizzera 4
IL - Israele 4
MU - Mauritius 4
EG - Egitto 3
KE - Kenya 3
KG - Kirghizistan 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
CM - Camerun 2
MA - Marocco 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
SC - Seychelles 1
UG - Uganda 1
Totale 49.656
Città #
Ann Arbor 7.832
Woodbridge 4.349
Fairfield 4.239
Houston 3.080
Ashburn 1.899
Dublin 1.864
Jacksonville 1.804
Wilmington 1.791
Seattle 1.609
Cambridge 1.397
Dearborn 1.360
Chandler 1.355
Hong Kong 1.198
Princeton 999
New York 809
Milan 615
Frankfurt am Main 544
Lawrence 478
Altamura 453
Nanjing 413
Lachine 309
San Diego 302
Beijing 296
Dong Ket 171
Nanchang 143
Andover 139
Shenyang 136
Hebei 120
Guangzhou 95
Falls Church 93
Ottawa 88
Norwalk 87
Toronto 78
Jiaxing 77
London 75
Tianjin 73
Shanghai 69
Boardman 67
Changsha 61
Jinan 58
Los Angeles 49
Detroit 48
Kunming 41
Helsinki 40
Vienna 37
Ningbo 36
San Mateo 36
Washington 36
Lissone 33
Huizen 31
Mountain View 31
Brussels 30
Fremont 30
Hangzhou 30
Zhengzhou 30
Redmond 27
Hefei 25
Philadelphia 21
Rome 21
Esslingen am Neckar 20
Hounslow 20
Taizhou 19
Groningen 18
Chicago 15
Edmonton 15
Fuzhou 15
Kilburn 14
Loreto 14
Pune 13
Busto Arsizio 11
Frontone 11
Phoenix 11
Taiyuan 11
University Park 11
Bologna 10
Edinburgh 10
New Bedfont 10
San Francisco 10
São Paulo 10
Tappahannock 10
Carate Brianza 9
Central 9
Chengdu 9
Hanoi 9
Islington 9
Lappeenranta 9
Prescot 9
Auburn Hills 8
Lanzhou 8
Laurel 8
Leawood 8
Monmouth Junction 8
Nürnberg 8
Perugia 8
Budapest 7
Buenos Aires 7
Dallas 7
Kiev 7
Orange 7
Palermo 7
Totale 41.696
Nome #
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 278
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 273
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 259
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 253
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 252
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 243
Cardiopulmonary receptor regulation of renin release 242
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 240
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 227
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 218
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 217
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 216
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 215
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 213
Renal and antihypertensive effects of felodipine in hypertensive patients 209
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 199
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 198
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 190
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 189
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 184
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 183
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 182
Clinical evaluation of a new antihypertensive drug (Indapamide) 180
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 180
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 176
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 175
Treatment of hypertension: The ESH/ESC guidelines recommendations 174
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 173
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 173
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 169
Blood pressure control in hypertension. Pros and cons of available treatment strategies 166
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 165
Incident Left Ventricular Hypertrophy in Masked Hypertension 164
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 163
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 162
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 161
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 161
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 160
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 159
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 159
The association between 24-h blood pressure patterns and left ventricular mechanics 159
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 158
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 158
How does blood pressure change in hypertensive patients with atrial fibrillation after successful electrical cardioversion? 157
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 157
Metabolic syndrome and multiple organ damage in essential hypertension 154
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 154
Metabolic syndrome and target organ damage: Role of blood pressure 150
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 150
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 149
Left ventricular geometry and diastolic function in the hypertensive heart: impact of age. 148
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 147
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 147
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 147
Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. 146
Prevalence and correlates of multiple organ damage in referred treated hypertensives: Data from the ETODH study 145
How does subclinical hyperthyroidism affect right heart function and mechanics? 145
Subclinical hyperthyroidism and biatrial function and mechanics: a two- and three-dimensional echocardiographic study 145
Right ventricular mechanics in patients with aortic stenosis and preserved ejection fraction: Is arterial hypertension a new player in the game? 143
Management of hypertension in patients with left ventricular hypertrophy 142
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 142
Neurogenic abnormalities in masked hypertension 141
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 141
Effects of the metabolic syndrome on right heart mechanics and function. 141
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 141
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 141
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 140
Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients 140
High-normal blood pressure and abnormal left ventricular geometric patterns: A meta-analysis 139
Metabolic syndrome and biventricular hypertrophy in essential hypertension 139
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 138
Indexation of left ventricular mass to body surface area and height to allometric power of 2,7: is the difference limited to obese hypertensives? 137
The impact of different left ventricular geometric patterns on right ventricular deformation and function in hypertensive patients 137
The Impact of White-Coat Hypertension on Cardiac Mechanics 137
Heart and Prehypertension 137
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 136
Is fetuin-A a biomarker of preclinical atherosclerosis in essential hypertension? 136
Cardiac and carotid structure in patients with established hypertension and white-coat hypertension 136
Extreme dipping: Always means nocturnal hypotension? 136
The relationship between functional capacity and left ventricular strain in patients with uncomplicated type 2 diabetes 135
Nocturnal hypertension and organ damage in dippers and nondippers 134
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 134
Masked hypertension: an independent predictor of organ damage 134
Nocturnal blood pressure in untreated essential hypertensives 133
Home and ambulatory blood pressure in resistant hypertension 133
Phasic Left Atrial Function in Cancer Patients Before Initiation of Anti-Cancer Therapy. 133
The Hyper-Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice 132
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 132
Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: A prospective observational study 132
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 131
Nocturnal Hypertension and Subclinical Cardiac and Carotid Damage: An Updated Review and Meta-Analysis of Echocardiographic Studies 131
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 130
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: a gender-based study. 130
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 130
Intriguing relationship between antihypertensive therapy and cancer 130
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 129
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure 129
Does the metabolic syndrome impact left-ventricular mechanics? A two-dimensional speckle tracking study. 129
How to Identify Hypertensive Patients at High Cardiovascular Risk? The Role of Echocardiography 129
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 128
Totale 16.294
Categoria #
all - tutte 165.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.379 0 0 0 0 0 0 0 0 0 0 1.249 1.130
2019/202010.893 1.380 551 794 976 1.061 1.421 1.438 860 1.059 439 646 268
2020/20219.462 546 504 811 1.000 621 919 1.068 1.097 773 949 401 773
2021/20226.263 472 536 887 442 392 367 359 406 415 380 515 1.092
2022/20236.265 1.083 1.784 392 399 364 1.078 83 304 400 69 211 98
2023/20244.753 142 111 112 187 920 1.379 966 86 741 106 3 0
Totale 51.667